Why GLP-1 medications are different from everything you've tried before
Over 42% of American adults are classified as obese. The vast majority of traditional diets fail within 12 months. The problem isn't willpower — it's biology. Your body has evolved sophisticated hormonal systems that resist weight loss, and until recently, medicine had no effective way to address them.
How GLP-1 receptor agonists work
Your body produces a hormone called GLP-1 (glucagon-like peptide-1) that signals fullness to your brain and regulates blood sugar. In many people who struggle with weight, this signaling system is impaired. GLP-1 medications restore and amplify these signals.
Mechanisms of Action
Appetite regulation — Activates satiety centers in the brain, naturally reducing hunger and food-seeking behavior.
Gastric motility — Slows stomach emptying so you feel fuller longer after eating.
Insulin response — Improves blood sugar regulation, eliminating the energy crashes that trigger overeating.
Reward modulation — Reduces the brain's compulsive reward response to food, making it easier to make healthy choices.
What the clinical data shows
The STEP trial program — among the largest obesity treatment studies ever conducted — demonstrated that participants using semaglutide achieved an average weight loss of 14.9% over 68 weeks. Newer formulations including tirzepatide have shown even greater results, with average losses exceeding 22% of body weight.
Beyond the scale, participants reported meaningful improvements in cardiovascular markers, joint pain, sleep quality, mobility, and self-reported mental health.
Who is eligible?
GLP-1 programs are generally appropriate for adults who meet the following criteria:
- BMI of 30 or higher, or BMI of 27+ with a weight-related health condition
- 18 years of age or older
- Have tried diet and exercise without lasting success
- Not pregnant or planning pregnancy
- No history of pancreatitis or medullary thyroid carcinoma
A licensed physician will review your complete medical history to determine if GLP-1 medication is clinically appropriate for you.